Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123145) titled 'Multicenter Cross-Sectional Observational Study Protocol on IgG Glycosylation Modifications in Primary Membranous Nephropathy' on April 22.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Shanghai East Hospital

Condition: Primary Membranous Nephropath

Intervention: Healthy control group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-01

Target Sample Size: Healthy control group:15;PMN patient group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=312387

Published by HT Digital Co...